• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Catalog Number FG540000
Device Problems Display or Visual Feedback Problem (1184); Poor Quality Image (1408)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/28/2023
Event Type  malfunction  
Manufacturer Narrative
The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event Description
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto® 3 system and a map shift issue occurred.It was reported by the caller, the bwi representative, that while creating the matrix with the octaray catheter, they started on ablation, continued to map while in the left atrium, and once they started to burn the left pulmonary vein on the ridge, they noticed a significant map shift.The caller reported that the map looked like it shifted up by approximately 20mm.The caller reported that electrode 2 was sometimes black, but they could create matrix.To troubleshoot the caller checked the metal values and made sure the spu was far enough away from everything without resolution.The caller created a new map, they experienced no further shifts, and the procedure was continued.On (b)(6) 2023, additional information received indicated there were no errors provided by the system.They observed that the octaray catheter was outside of the initial map created.The issue was seen during ablation.No cardioversion or patient movement.The patient was on ¿jet¿ the entire case.This event was originally considered nonreportable, however, bwi became aware of additional information on (b)(6) 2023 and have reassessed the event as an mdr reportable malfunction for the map shift.
 
Manufacturer Narrative
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto® 3 system and a map shift issue occurred.It was reported by the caller, the bwi representative, that while creating the matrix with the octaray catheter, they started on ablation, continued to map while in the left atrium, and once they started to burn the left pulmonary vein on the ridge, they noticed a significant map shift.The caller reported that the map looked like it shifted up by approximately 20mm.The caller reported that electrode 2 was sometimes black, but they could create matrix.To troubleshoot the caller checked the metal values and made sure the spu was far enough away from everything without resolution.The caller created a new map, they experienced no further shifts, and the procedure was continued.On 31-aug-2023, additional information received indicated there were no errors provided by the system.They observed that the octaray catheter was outside of the initial map created.The issue was seen during ablation.No cardioversion or patient movement.The patient was on ¿jet¿ the entire case.Device evaluation details: it was confirmed that the issue was not duplicated in the following case.The system is ready for use.An investigation was initiated by the manufacturer to investigate the issue.The provided data was insufficient to conduct investigation, no more data was available.The manufacturing record evaluation was performed on carto 3 #14692, and no internal actions related to the reported complaint condition were identified.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# pc-(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO® 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS   2066717
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key17821665
MDR Text Key324334333
Report Number2029046-2023-02167
Device Sequence Number1
Product Code DQK
UDI-Device Identifier10846835000870
UDI-Public10846835000870
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133916
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberFG540000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/31/2023
Initial Date FDA Received09/26/2023
Supplement Dates Manufacturer Received11/02/2023
Supplement Dates FDA Received11/19/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/30/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
UNK_OCTARAY NAV.
-
-